2023-10-01 2024-09-30 false Capium Accounts Production 1.1 11559729 2023-10-01 2024-09-30 11559729 bus:AbridgedAccounts 2023-10-01 2024-09-30 11559729 bus:FRS102 2023-10-01 2024-09-30 11559729 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 11559729 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 11559729 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 11559729 2023-10-01 2024-09-30 11559729 2024-09-30 11559729 bus:RegisteredOffice 2023-10-01 2024-09-30 11559729 core:WithinOneYear 2024-09-30 11559729 core:AfterOneYear 2024-09-30 11559729 1 2023-10-01 2024-09-30 11559729 bus:Director1 2023-10-01 2024-09-30 11559729 bus:Director1 2024-09-30 11559729 bus:Director1 2022-10-01 2023-09-30 11559729 2022-10-01 11559729 bus:LeadAgentIfApplicable 2023-10-01 2024-09-30 11559729 2022-10-01 2023-09-30 11559729 2023-09-30 11559729 core:WithinOneYear 2023-09-30 11559729 core:AfterOneYear 2023-09-30 11559729 bus:EntityAccountantsOrAuditors 2022-10-01 2023-09-30 11559729 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 11559729 core:CostValuation core:Non-currentFinancialInstruments 2023-09-30 11559729 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-09-30 11559729 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 11559729 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-09-30 11559729 core:Non-currentFinancialInstruments 2024-09-30 11559729 core:Non-currentFinancialInstruments 2023-09-30 11559729 core:ShareCapital 2024-09-30 11559729 core:ShareCapital 2023-09-30 11559729 core:RetainedEarningsAccumulatedLosses 2024-09-30 11559729 core:RetainedEarningsAccumulatedLosses 2023-09-30 11559729 dpl:Item1 2023-10-01 11559729 dpl:Item1 2024-09-30 11559729 dpl:Item1 2022-10-01 11559729 dpl:Item1 2023-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11559729
England and Wales

 

 

 

MEDIVIT LTD



Abridged Accounts
 


Period of accounts

Start date: 01 October 2023

End date: 30 September 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Investments 3 1,216,296    1,216,296 
1,216,296    1,216,296 
Current assets      
Cash at bank and in hand 9,806    9,375 
Creditors: amount falling due within one year (357,817)   (331,071)
Net current assets (348,011)   (321,696)
 
Total assets less current liabilities 868,285    894,600 
Creditors: amount falling due after more than one year (838,450)   (873,967)
Net assets 29,835    20,633 
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account 29,735    20,533 
Shareholders' funds 29,835    20,633 
 


For the year ended 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the profit and loss account has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 22 September 2025 and were signed by:


-------------------------------
Venkat Ramana Reddy ADAMA
Director
1
General Information
MEDIVIT LTD is a private company, limited by shares, registered in England and Wales, registration number 11559729, registration address 9, Fairway Drive, Chelmsford, CM3 3FG.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Fixed asset investments
Fixed asset investments are stated at cost less provision for any permanent diminution in value.
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).
3.

Investments

Cost Other investments other than loans   Total
  £   £
At 01 October 2023 1,216,296    1,216,296 
Additions  
Disposals  
At 30 September 2024 1,216,296    1,216,296 

2